Form 4 for EOG EOG Resources
Accepted 2026-04-02 12:02:46 ET · period of report 2026-03-31 · accession 0000821189-26-000074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-04-02 12:02 | 2026-03-31 | EOG | Leitzell Jeffrey R. | EVP, COO | M - OptEx | $56.26 | +15.0K | 98.3K | +18% | +$844.0K |
| DM | 2026-04-02 12:02 | 2026-03-31 | EOG | Leitzell Jeffrey R. | EVP, COO | D - Sale to Iss | $150.57 | -5,605 | 94.9K | -6% | -$844.0K |
| DM | 2026-04-02 12:02 | 2026-03-31 | EOG | Leitzell Jeffrey R. | EVP, COO | F - Tax | $150.65 | -3,699 | 93.7K | -4% | -$557.3K |
| D | 2026-04-02 12:02 | 2026-03-31 | EOG | Leitzell Jeffrey R. | EVP, COO | S - Sale+OE | $150.32 | -5,698 | 88.0K | -6% | -$856.5K |
| DM | 2026-04-02 12:02 | 2026-03-31 | EOG | Leitzell Jeffrey R. | EVP, COO | M - OptEx | $0.00 | -15.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-31 | M | A | 8,640 | $37.44 | 96,685.49 | D | — | — | (F1) The SARs granted became exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs became fully exercisable on September 28, 2023. |
| 2 | Common | Common Stock | 2026-03-31 | D | D | 2,146 | $150.74 | 94,539.49 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-31 | F | D | 2,556 | $150.74 | 91,983.49 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-31 | M | A | 6,362 | $81.81 | 98,345.49 | D | — | — | (F2) The SARs granted became exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 27, 2021 date of grant. The SARs became fully exercisable on September 27, 2024. |
| 5 | Common | Common Stock | 2026-03-31 | D | D | 3,459 | $150.47 | 94,886.49 | D | — | — | |
| 6 | Common | Common Stock | 2026-03-31 | F | D | 1,143 | $150.47 | 93,743.49 | D | — | — | |
| 7 | Common | Common Stock | 2026-03-31 | S | D | 5,698 | $150.32 | 88,045.49 | D | — | — | |
| 8 | Derivative | Stock Appreciation Rights | 2026-03-31 | M | D | 8,640 | $0.00 | 0 | D | $37.44 · 2021-09-28 to 2027-09-28 | 8,640 Common Stock | (F1) The SARs granted became exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs became fully exercisable on September 28, 2023. |
| 9 | Derivative | Stock Appreciation Rights | 2026-03-31 | M | D | 6,362 | $0.00 | 0 | D | $81.81 · 2022-09-27 to 2028-09-27 | 6,362 Common Stock | (F2) The SARs granted became exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 27, 2021 date of grant. The SARs became fully exercisable on September 27, 2024. |